CARCINOMAS
Clinical trials for CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new CARCINOMAS trials appear
Sign up with your email to follow new studies for CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to prevent lung cancer recurrence in High-Risk patients
⭐️ VACCINE ⭐️ TerminatedThis study tests a vaccine made from lung cancer cells, combined with an immune-boosting drug (N-803), to see if it can prevent non-small cell lung cancer from returning after surgery. About 30 adults with no signs of cancer after surgery will receive the vaccine as shots under t…
Matched conditions: CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:01 UTC
-
New drug combo offers hope for rare, aggressive kidney cancer
Disease control OngoingThis study tests whether two immunotherapy drugs, nivolumab and relatlimab, can help control a rare and aggressive kidney cancer called renal medullary carcinoma (RMC). About 30 adults with advanced or spread RMC will receive the drug combination. The goal is to see how many pati…
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:12 UTC
-
New hope for rare cervical cancer: drug trial targets tumor control
Disease control OngoingThis study tests a drug called AK104 (cadonilimab) in 18 adults with a rare and fast-growing type of cervical cancer that has come back or spread. The goal is to see if the drug can stop the cancer from growing for at least 6 months. Participants must have already tried standard …
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC